02505cam a2200481 i 4500 ocn968332771 OCoLC 20181126145413.0 170113s2016 dcua b f000 0 eng c GPO eng rda GPO GPO OCLCQ OCLCF WLU AZP GPO OCLCA OCLCQ MvI pcc n-us--- KF31.5 .A3 2016a 1008-C Y 1.1/5:114-429 Y 1.1/5:114-429 United States. Congress. Senate. Special Committee on Aging, author. Special report of the U.S. Senate Special Committee on Aging on the sudden price spikes in off-patent prescription drugs : the monopoly business model that harms patients, taxpayers, and the U.S. health system. Sudden price spikes in off-patent prescription drugs : the monopoly business model that harms patients, taxpayers, and the U.S. health system Washington : U.S. Government Publishing Office, 2016. Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office iii, 130 pages : illustrations ; 24 cm. txt n rdamedia nc rdacarrier Report / 114th Congress, 2d session, Senate ; 114-429 Shipping list no.: 2017-0119-P. "December 20, 2016." CRDP Program record. Includes bibliographical references. Prescription pricing United States. Drugs Prices United States. Generic drugs United States. Antitrust law United States. Competition United States. Consumer protection United States. Pharmaceutical industry Moral and ethical aspects United States. Legislative materials. lcgft Online version: United States. Congress. Senate. Special Committee on Aging. Special report of the U.S. Senate Special Committee on Aging on the sudden price spikes in off-patent prescription drugs (OCoLC)968332603 Microfiche version: United States. Congress. Senate. Special Committee on Aging. Special report of the U.S. Senate Special Committee on Aging on the sudden price spikes in off-patent prescription drugs (OCoLC)993255674 United States. Congress. Senate. Report ; 114-429. BEV Fed Docs 276401 276401